Mounjaro 2.5mg Vial Of 0.5ml Solution For Injection
Description
Mounjaro solution for injection is a prescription medication used to improve blood sugar control in adults with type 2 diabetes alongside diet and exercise. Mounjaro solution for injection is not intended for individuals with type 1 diabetes.
Common side effects of Mounjaro solution for injection may include nausea, diarrhea, vomiting, constipation, abdominal pain, and indigestion. These symptoms are generally mild and tend to improve over time. However, if they become severe or last a long time, it's important to consult a doctor.
Mounjaro solution for injection is not recommended for those with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN2). Pregnant individuals or those planning to conceive should avoid this medication due to potential risks to the developing baby.
Before starting this treatment, please inform your doctor of all other medications you are taking to prevent interactions.
Product Summary
Offer Price | ₹3500.00 |
You Save | |
Contains | Tirzepatide(2.5 Mg/0.5ml) |
Uses | Type 2 diabetes mellitus |
Side effects | Nausea, diarrhea, decreased appetite, vomiting, constipation, dyspepsia, and abdominal pain. |
Therapy | ANTI-DIABETIC |
Uses of Mounjaro 2.5 MG/0.5ML
Contraindications of Mounjaro 2.5 MG/0.5ML
Side effects of Mounjaro 2.5 MG/0.5ML
- Abdominal pain
- Constipation
- Indigestion
- Nausea
- Diarrhea
- Vomiting
Precautions and Warnings of Mounjaro 2.5 MG/0.5ML
Pregnancy
Breast Feeding
Driving
Alcohol
Other General Warnings
- You have a history of pancreatitis.
- You experience severe abdominal pain, nausea, or vomiting, which could be signs of pancreatitis.
- You have type 2 diabetes and are taking insulin or a sulfonylurea, as you may be at increased risk of hypoglycemia.
- You experience frequent nausea, vomiting, or diarrhea, which may lead to dehydration and kidney problems.
- You have kidney disease, have had a kidney transplant, or have liver disease.
- You are elderly, especially if you are over 85 years old, as limited data is available on safety in this age group.
- You have severe gastrointestinal disease, including gastroparesis, as tirzepatide has not been studied in such patients.
- You have diabetic retinopathy or diabetic macular edema, as tirzepatide should be used with caution in these conditions.
- You are scheduled for a procedure requiring general anesthesia or deep sedation, as there is an increased risk of pulmonary aspiration.
- You notice any unusual changes in your vision while using tirzepatide.
Directions for Use of Mounjaro 2.5 MG/0.5ML
Storage and disposal of Mounjaro 2.5 MG/0.5ML
- Store Mounjaro solution for injection in a refrigerator at a temperature between 2°C to 8°C.
- If necessary, each single-dose pen or vial can be kept unrefrigerated at temperatures not exceeding 30ºC for up to 21 days.
- Do not freeze Mounjaro, and do not use this medicine if it has been frozen.
- Store it in the original carton to protect it from light.
Dosage of Mounjaro 2.5 MG/0.5ML
Overdose
Missed a Dose
Mode of Action of Mounjaro 2.5 MG/0.5ML
How Does It Work?
Interactions of Mounjaro 2.5 MG/0.5ML
Interactions with other medicines
- Taking oral medications with a narrow therapeutic index, such as warfarin or digoxin, may be affected by tirzepatide, as it can alter their absorption.
- Using medications that require a rapid onset of action might be problematic since tirzepatide may delay their effects.
- Relying on oral contraceptives may be risky, as tirzepatide could reduce their effectiveness. It is advisable to consider switching to a non-oral contraceptive method or to use additional protection for four weeks after starting tirzepatide or increasing its dose....
- Having obesity or being overweight while using oral contraceptives may be concerning since tirzepatide can influence their efficacy.
- Frequently taking paracetamol might be impacted by tirzepatide, as it may delay its absorption; however, no dose adjustment is typically necessary.
Content Details

Ravindra Ghongade
B. Pharm

Dr. Nikita Toshi
BDS (Bachelor of Dental Surgery), WHO FIDES member
References
- Lilly.com | Eli Lilly and Company [Internet]. www.lilly.com. [Cited 28 March 2025]
- Mounjaro KwikPen 2.5mg solution for injection in pre-filled pen - Summary of Product Characteristics (SmPC) - (emc) [Internet]. www.medicines.org.uk. [Cited 28 March 2025]
- MOUNJAROTM (tirzepatide) Injection, for subcutaneous use Initial U.S. Approval: 2022 [Internet]. uspl.lilly.com. [Cited 28 March 2025]
Did you find this medicine information helpful?
Please rate your experience
Other Products from this Brand
Health Articles
Top-Tests we cover:
Top-Selling Healthcare Products:
Top-Selling Medicines:
Top-Searched Medicines: